Insight into drug resistance mechanisms and discovery of potential inhibitors against wild-type and L1196M mutant ALK from FDA-approved drugs.
about
The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer.Structure and energy based quantitative missense variant effect analysis provides insights into drug resistance mechanisms of anaplastic lymphoma kinase mutations.
P2860
Insight into drug resistance mechanisms and discovery of potential inhibitors against wild-type and L1196M mutant ALK from FDA-approved drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@en
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@nl
type
label
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@en
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@nl
prefLabel
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@en
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@nl
P2093
P2860
P1476
Insight into drug resistance m ...... t ALK from FDA-approved drugs.
@en
P2093
P2860
P2888
P356
10.1007/S00894-016-3099-5
P577
2016-09-01T00:00:00Z